Kevin G. King

Kevin G. King

Auto-generated profile, based on publicly available information

Kevin G. King

David Geffen School of Medicine at UCLA, Los Angeles, CA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2022 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
JLJustin Lee
Justin Lee
KKKevin G. King
Kevin G. King
SCShefali Chopra
Shefali Chopra
PCPhillip M. Cheng
Phillip M. Cheng

6 April 2026 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
WZWeihua Zeng
Weihua Zeng
CLChun-Chi Liu
Chun-Chi Liu
SLShuo Li
Shuo Li
YZYonggang Zhou
Yonggang Zhou
MSMary L. Stackpole
Mary L. Stackpole
XZXianghong Jasmine Zhou
Xianghong Jasmine Zhou
Plasma cell-free DNA (cfDNA), originating from multiple organs, holds significant potential for noninvasive diagnostics and prognostics. Current cfDNA methylation assays primarily focus on single clinical indications by targeting specific genomic loci. In contrast, comprehensive profiling of cfDNA methylome can enable simultaneous detection of multiple diseases by capturing organ-specific methylation signatures, thereby offering a holistic view of health, when disease etiology is unclear or when conventional biochemical diagnostics are unavailable. However, deep sequencing required for sensitive detection of methylation abnormalities remains prohibitively expensive, limiting widespread clinical use. To overcome this barrier, we developed MethylScan , a highly cost-effective approach for cfDNA methylome sequencing. We demonstrated its broad clinical utility in a cohort of 1,061 individuals across diverse applications, including multicancer detection in general population, liver cancer surveillance in high-risk individuals, liver disease classification, identification of organ abnormalities, and race prediction from cfDNA. In multicancer detection (liver, lung, ovarian, and stomach cancers), MethylScan achieved an area under the receiver operating characteristic curve (AUROC) of 0.938 (95% CI: 0.920 to 0.954), with a sensitivity of 63.3% (95% CI: 58.9 to 67.9%) at 98.0% specificity for all cancer stages. For early-stage cancers, the AUROC was 0.916 (95% CI: 0.890 to 0.940), with 55.3% sensitivity (95% CI: 49.1 to 62.1%) at the same specificity. In liver cancer surveillance, MethylScan achieved an AUROC of 0.927 (95% CI: 0.889 to 0.959), with 79.6% sensitivity (95% CI: 70.6 to 87.8%) at 90.4% specificity. The assay also demonstrated strong performance in additional diagnostic tasks, supporting its potential as a versatile platform for comprehensive cfDNA-based health monitoring.

1 September 2022 in American Journal of Roentgenology
Verified
Journal Article
Closed access
KKKevin G. King
Kevin G. King
This Editorial Comment discusses the following AJR article: Contrast-Enhanced Ultrasound Using Perfluorobutane: Impact of Proposed Modified LI-RADS Criteria on Hepatocellular Carcinoma Detection.

1 January 2023 in Hepatoma Research
Verified
Journal Article
Closed access
KKKevin G. King
Kevin G. King
JDJena Depetris
Jena Depetris
MPMaitraya K. Patel
Maitraya K. Patel
SRSteven S. Raman
Steven S. Raman
DLDavid S. Lu
David S. Lu
Hepatoma Research is an open access journal and focuses on all topics related to hepatoma. The following articles are especially welcome: pathogenesis, clinical examination and early diagnosis of hepatoma, complications of hepatoma, and their preventions and treatments, etc.

17 February 2023 in Abdominal Radiology
Verified
Journal Article
Open access
PDF file
JLJustin Lee
Justin Lee
KKKevin G. King
Kevin G. King
SCShefali Chopra
Shefali Chopra
PCPhillip M. Cheng
Phillip M. Cheng
The original version of this article unfortunately contained a mistake. In particular, the figure part labels were missing, and Figs. 7 and 8 were switched. In the visual abstract, citation information was missing. The corrected figures are provided below. The original article has been updated.

1 April 2017 in Journal of Urology
Verified
Journal Article
Open access
PDF file
SCSameer Chopra
Sameer Chopra
IGInderbir Gill
Inderbir Gill
ABAlfredo Maria Bove
Alfredo Maria Bove
CFCarlos Fay
Carlos Fay
KKKevin King
Kevin King
RSRalf Seip
Ralf Seip